Alle Storys
Folgen
Keine Story von Biosafe Group mehr verpassen.

Biosafe Group

Biosafe achieves full registration in China

Switzerland (ots)

Biosafe is proud to report that it has just received the official registration of its single use disposable kits with the Chinese FDA. Following earlier approval of the Company's Sepax cell processing machine, Biosafe is now primed to launch sales of its products in the People's Republic of China.

Olivier Waridel, CEO of the Biosafe Group commented: "We are the only company in our field which has received CFDA approval for both its equipment and kits. We are now eager to offer our industry- leading products throughout the People's Republic of China, having set up a Shanghai-based subsidiary in 2012 already. We have been in contact with a number of major Chinese companies and institutions, which will now be able to access our state of the art technology. We see tremendous potential both in the cord blood banking and regenerative medicine markets".

Biosafe's Sepax device, used in conjunction with its proprietary single use disposable kits, offers a wide range of applications in cord blood banking and in the rapidly developing regenerative medicine area. It is used in a point of care environment such as cardiovascular and orthopedic, while in biotechnology and pharmaceutical processes it provides a versatile cell processing platform. Biosafe also offers a range of complementary products, such as the recently launched Smart-Max, for the preparation of cellular products.

About the Biosafe Group

Founded in 1997 the Biosafe Group is active in the design, manufacture and marketing of automated cell processing systems. Headquartered in Switzerland and privately-owned, the Biosafe Group operates through regional subsidiaries (Geneva, Houston, Hong-Kong, Shanghai and São Paulo) and is present in more than 50 countries, either directly or through distributors.

Contact:

Christopher Bolton
CFO Biosafe Group SA
+41-22-365-27-27
christopher.bolton@biosafe.ch
www.biosafe.ch

Weitere Storys: Biosafe Group
Weitere Storys: Biosafe Group
  • 12.12.2013 – 07:00

    BIOSAFE targets Latin American expansion

    Eysins, Switzerland (ots) - Following the set-up of a Shanghai-based Chinese subsidiary and its recent expansion in India, Biosafe is demonstrating its firm commitment to emerging markets with the creation of a new subsidiary and the opening today of a new office covering the Latin American area. The new company, Biosafe do Brasil Participaçôes e Representações Ltda., based in the Vila Olímpia quarter of São Paulo ...

  • 28.10.2013 – 07:00

    BIOSAFE's latest innovation: Smart-Max

    Eysins, Switzerland (ots) - Biosafe is pleased to report the launch of its new Smart-Max device at the ESH World Cord Blood Congress in Monaco last week. The Smart-Max device has multiple areas of application in cell processing, including cell mixing, cooling, thawing, dilution, incubation and digestion. It is fully automated with an easy-to-use touchscreen interface and can handle bags of various sizes. Used in ...

  • 23.09.2013 – 07:00

    BIOSAFE affirms its leadership in India

    Eysins, Switzerland (ots) - Biosafe is pleased to announce that, in partnership with its Indian Distributor Span Healthcare Private Ltd., it has achieved major expansion of its stem cell banking business in India, winning major new customer deals consecutively. In the public stem cell banking area, Jeevan Blood Bank and Research Centre in Chennai is expanding its program and will process its full volume of stem cell ...